Immunological routine laboratory parameters at admission influence the improvement of positive symptoms in schizophrenia patients after pharmacological treatment

Bibliographic Data

ID15529362
AuthorsAnna Skalniak (0000-0001-7871-9347, Jagiellonian University), Wirginia Krzyściak (0000-0003-0452-295X, Jagiellonian University, corresponding author), Natalia Śmierciak (0000-0003-3174-4929, Jagiellonian University), Marta Szwajca (0000-0002-0666-0072, Jagiellonian University), Paulina Donicz (Jagiellonian University), Tamás Kozicz (0000-0001-6915-4364, Mayo Clinic in Florida), Maciej Pilecki (0000-0001-8005-2182, Jagiellonian University)
Year2023
Volume14
Pages1082135-1082135
Publication date2023-03-22
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2023.1082135
PMID37032951
OpenAlexW4353082267
LanguageEN
Citations received1
References cited35

We show that objective markers can be obtained by testing immune and metabolic parameters from the patients' blood and may be added at a low cost to the standard care of schizophrenia patients in order to predict the outcome of pharmacological treatment

Decompensation · Positive and Negative Syndrome Scale · Psychiatry · Psychosis · Schizophrenia (object-oriented programming · Clinical Psychology · Gut microbiota and health · Medicine · Psychology · Schizophrenia research and treatment · Tryptophan and brain disorders · Internal Medicine

Tools

Open DOIOpen Access